Zhen Zeng Selected Research

Intergenic DNA (Junk DNA)

1/2021	OFCC1-ALK (Ointergenic: A20): A novel OFCC1 intergenic region-ALK fusion identified from a lung adenocarcinoma patient.
7/2011	A genome-wide association study reveals association between common variants in an intergenic region of 4q25 and high-grade myopia in the Chinese Han population.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Zhen Zeng Research Topics

Disease

29	Neoplasms (Cancer) 01/2022 - 09/2010
21	Hepatocellular Carcinoma (Hepatoma) 03/2021 - 09/2010
10	Fibrosis (Cirrhosis) 01/2022 - 12/2012
7	Inflammation (Inflammations) 01/2022 - 02/2011
5	Uterine Cervical Neoplasms (Cancer of the Cervix) 03/2022 - 01/2020
5	Infections 01/2022 - 11/2017
5	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2022 - 01/2018
4	Acute Lung Injury 03/2022 - 04/2015
4	Breast Neoplasms (Breast Cancer) 01/2022 - 01/2018
4	Lung Neoplasms (Lung Cancer) 01/2022 - 01/2018
4	Neoplasm Metastasis (Metastasis) 09/2021 - 02/2013
4	Ankylosing Spondylitis 11/2014 - 02/2011
3	Nasopharyngeal Carcinoma 01/2021 - 10/2018
3	Liver Cirrhosis (Hepatic Cirrhosis) 12/2020 - 07/2010
3	Clostridium Infections 02/2020 - 01/2020
3	Carcinoma (Carcinomatosis) 10/2018 - 02/2013
3	Autoimmune Diseases (Autoimmune Disease) 05/2013 - 02/2011
3	Liver Neoplasms (Liver Cancer) 02/2013 - 10/2011
2	Obesity 11/2022 - 11/2012
2	Body Weight (Weight, Body) 11/2022 - 01/2022
2	Adenocarcinoma of Lung 01/2022 - 01/2021
2	Asthma (Bronchial Asthma) 01/2022 - 01/2020
2	Chronic Obstructive Pulmonary Disease (COPD) 01/2022 - 12/2021
2	Polycystic Ovary Syndrome (Syndrome, Stein-Leventhal) 01/2022 - 01/2021
2	Rheumatoid Arthritis 01/2022 - 05/2013
2	COVID-19 01/2022 - 12/2021
2	Critical Illness (Critically Ill) 04/2021 - 01/2020
2	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 01/2021 - 03/2020
2	Disease Progression 01/2021 - 10/2011
2	Ischemic Stroke 01/2021 - 12/2019
2	Systemic Scleroderma (Systemic Sclerosis) 12/2020 - 02/2011
2	Pulmonary Fibrosis (Fibrosing Alveolitis) 12/2020 - 01/2018
2	Hypoxia (Hypoxemia) 08/2020 - 01/2016
2	Pain (Aches) 02/2020 - 08/2019
2	Pneumonia (Pneumonitis) 01/2020 - 01/2018
2	Cholangiocarcinoma 01/2020 - 11/2018
2	Prostatic Neoplasms (Prostate Cancer) 10/2018 - 02/2013
2	Carcinogenesis 01/2018 - 10/2016
2	Dehydration (Water Stress) 11/2017 - 08/2017
2	Cicatrix (Scar) 08/2017 - 04/2012
2	Lung Injury 01/2016 - 04/2015
2	Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome) 01/2016 - 05/2005
2	Schizophrenia (Dementia Praecox) 05/2013 - 06/2012
2	End Stage Liver Disease 10/2011 - 11/2010
2	Diabetic Nephropathies (Diabetic Nephropathy) 06/2011 - 04/2010
1	Dyslipidemias (Dyslipidemia) 11/2022

Drug/Important Bio-Agent (IBA)

8	Biomarkers (Surrogate Marker)IBA 01/2022 - 11/2012
7	Pharmaceutical PreparationsIBA 12/2021 - 08/2011
6	LipopolysaccharidesIBA 03/2022 - 04/2015
6	CytokinesIBA 01/2021 - 09/2010
5	Proteins (Proteins, Gene)FDA Link 09/2021 - 02/2013
5	Messenger RNA (mRNA)IBA 01/2021 - 01/2018
4	Angiotensin-Converting Enzyme 2IBA 03/2022 - 04/2015
4	AntioxidantsIBA 01/2022 - 08/2017
4	Sorafenib (BAY 43-9006)FDA Link 01/2018 - 02/2012
3	sinapinic acidIBA 11/2022 - 01/2020
3	Antiviral Agents (Antivirals)IBA 12/2021 - 11/2014
3	Long Noncoding RNAIBA 01/2021 - 01/2018
3	bezlotoxumabIBA 02/2020 - 01/2020
3	Interleukin-23 (Interleukin 23)IBA 01/2020 - 02/2011
3	LigandsIBA 01/2018 - 01/2011
2	Letrozole (Femara)FDA LinkGeneric 01/2022 - 01/2021
2	EnzymesIBA 01/2022 - 01/2020
2	OvalbuminIBA 01/2022 - 01/2020
2	Circular RNAIBA 01/2022 - 08/2020
2	InterferonsIBA 12/2021 - 11/2017
2	Angiotensin IIIBA 11/2021 - 04/2015
2	Estrogen ReceptorsIBA 11/2021 - 01/2018
2	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 11/2021 - 03/2020
2	tazobactam drug combination ceftolozaneIBA 04/2021 - 01/2020
2	Cisplatin (Platino)FDA LinkGeneric 01/2021 - 10/2018
2	Intergenic DNA (Junk DNA)IBA 01/2021 - 07/2011
2	AntigensIBA 01/2021 - 05/2020
2	Immune Checkpoint InhibitorsIBA 01/2021 - 01/2018
2	Small Interfering RNA (siRNA)IBA 12/2020 - 01/2016
2	Doxorubicin (Adriamycin)FDA LinkGeneric 08/2020 - 01/2017
2	NucleotidesIBA 02/2020 - 02/2013
2	InflammasomesIBA 01/2020 - 07/2012
2	Interleukin-17 (Interleukin 17)IBA 01/2020 - 02/2011
2	MicroRNAs (MicroRNA)IBA 01/2018 - 01/2017
2	Transcription Factors (Transcription Factor)IBA 01/2018 - 10/2010
2	AnionsIBA 11/2017 - 08/2017
2	KIR ReceptorsIBA 11/2014 - 05/2013
2	ElementsIBA 01/2014 - 02/2013
1	CholesterolIBA 11/2022
1	HDL CholesterolIBA 11/2022
1	LDL CholesterolIBA 11/2022
1	Triglycerides (Triacylglycerol)IBA 11/2022

Therapy/Procedure

18	Therapeutics 01/2022 - 06/2012
10	Cryosurgery 05/2015 - 09/2010
8	Drug Therapy (Chemotherapy) 01/2022 - 12/2012
6	Cryotherapy (Therapy, Cold) 03/2015 - 10/2011
3	Aftercare (After-Treatment) 02/2020 - 05/2015
2	Hysterectomy 03/2022 - 01/2020
2	Radiotherapy 08/2021 - 01/2018
2	General Anesthesia 04/2021 - 01/2010
2	Immunotherapy 01/2021 - 01/2018
2	Chemoradiotherapy 01/2020 - 10/2018
2	Induction Chemotherapy 01/2019 - 10/2018
2	Chinese Traditional Medicine (Traditional Chinese Medicine) 11/2014 - 08/2011